What's on the Horizon in Atopic Dermatitis? A Focus on OX40-OX40 Ligand-Targeted Therapies
Listen now
Description
Did you know that targeting the OX40-OX40 ligand (OX40-OX40L) pathway may lead to long-term remission in atopic dermatitis (AD)?
Credit available for this activity expires: 6/26/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001214?ecd=bdc_podcast_libsyn_mscpedu
More Episodes
Did you know agitation is a treatable entity among patients with Alzheimer’s disease? Learn about potential causes and treatments for agitation.
Credit available for this activity expires: 10/29/25
Earn Credit / Learning Objectives & Disclosures:...
Published 10/29/24
Published 10/29/24
Top tips for informed conversations with patients and their families around this new class of drugs for Alzheimer’s disease (AD).
Credit available for this activity expires: 10/28/25
Earn Credit / Learning Objectives & Disclosures: ...
Published 10/29/24
Links
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
